Female Permanent Contraception Trends and Updates

Author(s):  
Nancy Z. Fang ◽  
Simone P. Advaney ◽  
Paula M. Castaño ◽  
Anne Davis ◽  
Carolyn L. Westhoff
2021 ◽  
Vol 18 (1) ◽  
Author(s):  
Rebecca Gormley ◽  
Brian Vickers ◽  
Brooke Cheng ◽  
Wendy V. Norman

Abstract Background Multiple options for permanent or long-acting contraception are available, each with adverse effects and benefits. People seeking to end their fertility, and their healthcare providers, need a comprehensive comparison of methods to support their decision-making. Permanent contraceptive methods should be compared with long-acting methods that have similar effectiveness and lower anticipated adverse effects, such as the levonorgestrel-releasing intrauterine contraception (LNG-IUC). We aimed to understand the comparability of options for people seeking to end their fertility, using high-quality studies. We sought studies comparing laparoscopic tubal ligation, hysteroscopic tubal occlusion, bilateral salpingectomy, and insertion of the LNG-IUC, for effectiveness, adverse events, tolerability, patient recovery, non-contraceptive benefits, and healthcare system costs among females in high resource countries seeking to permanently avoid conception. Methods We followed PRISMA guidelines, searched EMBASE, Pubmed (Medline), Web of Science, and screened retrieved articles to identify additional studies. We extracted data on population, interventions, outcomes, follow-up, health system costs, and study funding source. We used the Newcastle–Ottawa Scale to assess risk of bias and excluded studies with medium–high risk of bias (NOS < 7). Due to considerable heterogeneity, we performed a narrative synthesis. Results Our search identified 6,612 articles. RG, BV, BC independently reviewed titles and abstracts for relevance. We reviewed the full text of 154 studies, yielding 34 studies which met inclusion criteria. We excluded 10 studies with medium–high risk of bias, retaining 24 in our synthesis. Most studies compared hysteroscopic tubal occlusion and/or laparoscopic tubal ligation. Most comparisons reported on effectiveness and adverse events; fewer reported tolerability, patient recovery, non-contraceptive benefits, and/or healthcare system costs. No comparisons reported accessibility, eligibility, or follow-up required. We found inconclusive evidence comparing the effectiveness of hysteroscopic tubal occlusion to laparoscopic tubal ligation. All studies reported adverse events. All forms of tubal interruption reported a protective effect against cancers. Tolerability appeared greater among tubal ligation patients compared to hysteroscopic tubal occlusion patients. No high-quality studies included the LNG-IUC. Conclusions Studies are needed to directly compare surgical forms of permanent contraception, such as tubal ligation or removal, with alternative options, such as intrauterine contraception to support decision-making. Systematic review registration PROSPERO [CRD42016038254].


2021 ◽  
pp. bmjsrh-2021-201062
Author(s):  
Xiaoyue Mona Guo ◽  
Marybeth Lore ◽  
Jessica Madrigal ◽  
Jessica Kiley ◽  
Katelyn Zumpf ◽  
...  

ObjectiveAlthough vasectomy is safer, more effective and less expensive than tubal ligation, rates of permanent contraception are consistently higher in women than in men. We sought to explore vasectomy interest and awareness in patients and their partners during prenatal visits, a time when contraceptive counselling is typically performed.MethodsAnonymous surveys were distributed between January and July 2019 to a cross-sectional, convenience sample of pregnant women and their partners, if available, presenting for outpatient prenatal care at two hospitals (one public, one private) serving different patient populations in Chicago, Illinois, USA. Survey questions gauged participant awareness and interest in vasectomies.ResultsSurveys were completed by 436 individuals (78% female, 24% male). Seventy percent of respondents indicated interest in vasectomy after achieving optimal family size, but most respondents had never discussed it with their healthcare provider. Factors associated with vasectomy interest included being partnered, having a lower household income, and knowing someone who has had a vasectomy. Almost 50% of respondents would be interested in obtaining information about vasectomies from their obstetrician or prenatal care provider.ConclusionsMany patients and their male partners in the prenatal clinic setting were interested in vasectomy as a method for permanent contraception, but most respondents had never received counselling. Since comprehensive prenatal care includes contraceptive planning, obstetric providers are uniquely positioned to educate individuals on vasectomy.


2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Joshua Amo-Adjei ◽  
Michael Mutua ◽  
Carol Mukiira ◽  
Namuunda Mutombo ◽  
Sherine Athero ◽  
...  

2012 ◽  
Vol 77 (6) ◽  
pp. 1056-1063 ◽  
Author(s):  
Erika C.S. Oliveira ◽  
Maria Raquel P. Moura ◽  
Marcelo J.C. de Sá ◽  
Valdemiro A. Silva ◽  
John P. Kastelic ◽  
...  

Contraception ◽  
2017 ◽  
Vol 96 (5) ◽  
pp. 330-335 ◽  
Author(s):  
Eva Patil ◽  
Amy Thurmond ◽  
Alison Edelman ◽  
Rongwei Fu ◽  
William Lambert ◽  
...  

2016 ◽  
Vol 2016 ◽  
pp. 1-5 ◽  
Author(s):  
Isamarie Lora Alcantara ◽  
Shadi Rezai ◽  
Catherine Kirby ◽  
Annika Chadee ◽  
Cassandra E. Henderson ◽  
...  

Background. Hysteroscopic tubal sterilization (Essure) is a minimally invasive option for permanent contraception with high reported rates of patient satisfaction. A small percentage of these women subsequently choose to have the tubal inserts removed due to regret or perceived side effects such as late-onset pelvic pain secondary to placement of the Essure device.Case. A twenty-nine-year-old woman G4P4014 presented with a two-year complaint of chronic pelvic pain and dyspareunia after the hysteroscopic placement of an Essure device for sterilization. On reviewing the images of the HSG, it was noted that although tubal occlusion was confirmed, the left Essure coil appeared curved on itself in an elliptical fashion and did not seem to follow the expected anatomic trajectory of the fallopian tube. The patient reported resolution of chronic pelvic pain following laparoscopic removal of Essure device.Conclusion. A misplaced Essure device should be considered in the differential diagnosis of chronic pelvic pain in women who had difficult placement of the device. In addition to demonstrating tubal occlusion, careful examination of the configuration of the Essure microinserts on HSG examination provides valuable information in patients with pelvic pain after Essure placement.


Contraception ◽  
2020 ◽  
Vol 101 (1) ◽  
pp. 40-45
Author(s):  
Eva Patil ◽  
Amy Thurmond ◽  
Kyle Hart ◽  
Jacqueline Seguin ◽  
Alison Edelman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document